The FDA has placed multiple investigational gene therapy clinical trials on hold, signaling broader platform concerns.

Separately, the FDA on Friday informally requested that Sarepta voluntarily pause shipments of another gene therapy, Elevidys, that is approved to treat a different type of muscular dystrophy and was ...

Sarepta says it will continue to ship Elevidys despite FDA requests that it stop shipments of the Duchenne muscular dystrophy gene therapy, while Verizon tops earnings expectation and raises 2025 ...

New board members bring decades of experience in company building, corporate strategy, commercialization, and business ...

U.S. stock futures moved higher Monday morning as Wall Street entered a pivotal week defined by high-stakes earnings from megacap tech giants and growing uncertainty surrounding President Trump’s ...

Evotec shares dipped 11.3% to $3.78 in the pre-market trading session. Here are some other stocks moving lower in pre-market trading.